Engineered immune cells injected directly into brain to fight cancer
NCT ID NCT02442297
Summary
This early-phase study is testing the safety of a new treatment for people with recurrent or treatment-resistant brain tumors that have a specific marker called HER2. Doctors take a patient's own immune cells (T cells), modify them in a lab to better recognize and attack the cancer, and then inject them directly into the brain. The main goal is to find the highest safe dose and understand the side effects of this experimental therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR, RECURRENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.